Edesa Biotech Inc (EDSA)

Finanzdaten der Edesa Biotech Inc-Aktie (EDSA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	43.03%3.96	2.77	1.12	1.23	0.94
Research and Development	43.03%3.96	2.77	1.12	1.23	0.94
Operating Income/Loss	28.45%-5.52	-4.30	-2.34	-2.47	-1.90
Nonoperating Income/Loss	40.87%0.11	0.08	0.09	0.24	0.15
Income/Loss From Continuing Operations Before Tax	28.22%-5.41	-4.22	-2.25	-2.23	-1.75
Income Tax Expense/Benefit	100.00%-	0.00	-	-	-
	28.19%-5.41	-4.22	-2.25	-2.23	-1.75
Attributable To Parent	28.19%-5.41	-4.22	-2.25	-2.23	-1.75
Basic Average Shares	5.46%9.01	8.54	7.97	0.46	7.02
Basic Earnings Per Share	22.45%-0.60	-0.49	-0.28	-0.32	-0.25